DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prandimet (Repaglinide / Metformin Hydrochloride) - Published Studies

 
 



Prandimet Related Published Studies

Well-designed clinical trials related to Prandimet (Repaglinide / Metformin)

Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. [2011.12]

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control. [2009.10]

Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet. [2009.09]

Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes. [2008.01]

Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin : Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects. [2008]

Other research related to Prandimet (Repaglinide / Metformin)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update. [2010.05.10]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017